Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.
about
Cyanobacteria blooms and non-alcoholic liver disease: evidence from a county level ecological study in the United StatesPNPLA3 mediates hepatocyte triacylglycerol remodelingNonalcoholic fatty liver disease: a comprehensive review of a growing epidemicAssociation between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort studyLifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trialsPreclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and PerspectiveThe Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment StrategyDietary habits and behaviors associated with nonalcoholic fatty liver diseaseTreatment of nonalcoholic steatohepatitis in adults: present and futureMagnetic resonance elastography of abdomen.Nutrition and metabolism in hepatocellular carcinomaNonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionineFatty liver disease in diabetes mellitusCardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An updateAlcoholic and non-alcoholic steatohepatitisObesity and psychotic disorders: uncovering common mechanisms through metabolomicsLipid-lowering agents in the management of nonalcoholic fatty liver diseaseTrypanosoma cruzi infection is a potent risk factor for non-alcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disordersGender-based disparities in access to and outcomes of liver transplantationConjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expressionThe Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver DiseasePsoriasis and comorbid diseases: Epidemiology.Gut Microbiota and Complications of Liver Disease.Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue?Promising therapies for treatment of nonalcoholic steatohepatitis.NAFLD and liver transplantation: Current burden and expected challenges.Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurementLong-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.Non-invasive methods for the diagnosis of nonalcoholic fatty liver diseaseAssociation between nocturnal hypoxia and liver injury in the setting of nonalcoholic fatty liver disease.Ultrasound in chronic liver disease.Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment.Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease.Can NASH be diagnosed, graded, and staged noninvasively?Phosphodiester content measured in human liver by in vivo 31 P MR spectroscopy at 7 tesla.Underestimation of liver-related mortality in the United States.Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-upLong-term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registry.A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.
P2860
Q21146668-3C5A2DA8-A97F-4A1E-8E15-EFB7563C1BA0Q24336530-AA6FAD86-7D57-4F68-8627-376C9C25A951Q24563381-A1828C62-E83A-48D1-ADDC-F738A305EB89Q24658538-2E42E480-6381-4F53-BD2C-096FCBB34F5BQ26748608-87060FBA-8A0C-419F-99CA-22F2EFD81842Q26768482-4E6FAAD4-E474-45E1-8EB2-4D878D5E7CABQ26780509-B50CD948-B29F-41B5-B02C-AEF08AE63A93Q26781753-FA1C536C-7308-42D4-9D57-90F0CF853016Q26830594-4E58C15E-06A4-4311-B317-73502F2B632FQ26852403-34688834-1DC9-43B3-8073-E24EC0D73B9FQ26852613-1445E1E1-BE7A-4F51-A4AA-39BB4D0B878DQ26862862-BCA1877C-D086-4502-83AA-EBBAD42E6616Q26992163-BA9B7812-E4A3-4501-B0BC-9F3F6AD2E036Q26996360-9F2CBE5D-EADA-491C-A2BA-291DC2DE31EEQ26997059-DF6026AD-64DC-4755-A7A4-8856FE7C6B06Q27000153-EF0BA260-A5F8-4876-89E2-176E761B42C1Q27011617-C18C8871-4A04-4326-9640-8EBA6361D3E9Q27024352-8C1B5B24-A714-4113-ABA8-BBE755188AD4Q27304622-39B24385-DAE8-4182-B9E0-3DE61E582010Q28083778-EB0B6CD5-4A0A-439F-828C-2D745C01B978Q28250778-1E05E9D7-BC30-4DD5-B26C-E68DE7D35C60Q28550881-1B1ECA10-63A7-41C3-8ED6-17103B2ED89AQ30235889-B5DD04F4-2D34-451D-B100-1F4C29503B45Q30236024-D3021C99-7B2D-4C4A-B041-CC7599318631Q30241648-946C248D-6F5B-4C1E-82B9-31C044E0816AQ30248578-AA7D5E98-A792-4547-8E0E-AD0717A372C3Q30248646-A2024FAE-3358-43B8-BDC6-26B5A851759CQ30389962-5B05873A-A677-44B5-8007-5E6E703946FBQ30412709-A54A722B-637E-469F-8D7B-0C43D9886F5AQ30414504-FDFAC463-440C-47F3-926D-4DE25007CC34Q30418433-E52E2278-53EC-480E-A9FA-9801D5B0BFDFQ30432218-F97C87D8-AFED-4B98-82E8-59E8B459DD16Q30434684-63913839-6A0F-4068-ABBB-D7D4DF4B7DEBQ30445138-7A391D35-D084-4793-AC9B-EBDAED132CB5Q30451362-62935E51-FE19-47E7-BA75-1835A3FB71D1Q30491010-06B854F6-1717-4AC2-9977-7F0A1623169DQ30564165-EAB805AE-DA64-41FE-8634-3A677DE809BEQ31132229-7D3A0100-CD2B-4173-8B94-B622C9485226Q31136569-9F42BFDD-6B71-426C-A73D-A9B3663ED856Q31171499-7E4AF59A-ACAD-43BD-95AE-DC0941910E06
P2860
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Changes in the prevalence of t ...... ited States from 1988 to 2008.
@en
Changes in the prevalence of t ...... ited States from 1988 to 2008.
@nl
type
label
Changes in the prevalence of t ...... ited States from 1988 to 2008.
@en
Changes in the prevalence of t ...... ited States from 1988 to 2008.
@nl
prefLabel
Changes in the prevalence of t ...... ited States from 1988 to 2008.
@en
Changes in the prevalence of t ...... ited States from 1988 to 2008.
@nl
P2093
P1476
Changes in the prevalence of t ...... ited States from 1988 to 2008.
@en
P2093
Hesham Mir
Manirath Srishord
Maria Stepanova
Mariam Afendy
Youssef Younossi
Zobair M Younossi
P304
524-530.e1; quiz e60
P356
10.1016/J.CGH.2011.03.020
P407
P577
2011-03-25T00:00:00Z